MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
FENC — Fennec Pharmaceuticals Inc. Common Stock
NasdaqFennec Pharmaceuticals Inc. Common Stock
$10.20
-0.13(-1.26%)
- O
- 10.46
- H
- 10.49
- L
- 10.03
- V
- 136.43K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About FENC
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateJan 28, 2002
Employees35
Stock ExchangeNasdaq
Ticker SymbolFENC
Websitehttps://www.fennecpharma.com
Key Financial Statistics
| Market Cap | $357.69M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $5.65 - $13.25 |
| 52-Week Avg Volume | 192.9K |
| VWAP | $10.18 |
| Transactions | 2,914 |
| Total Recorded Bars | 2,274 days |